{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F9c230156-7a49-4ef2-a9fb-f6a04ff991b4","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Insights from AAPS PharmSci 360 Live with Dr. Mark Arnold\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/9c230156-7a49-4ef2-a9fb-f6a04ff991b4\"></iframe>","title":"Insights from AAPS PharmSci 360 Live with Dr. Mark Arnold","description":"In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discuss the impact of recent FDA regulations on drug development, the importance of community support through the Samaritan Purse charity, especially on recent hurricane victims, and the exciting advancements in RNA editing technologies. The conversation highlights the collaborative nature of the pharmaceutical industry and the drive behind bioanalytical work, emphasizing the ultimate goal of delivering effective therapies to patients. \r\n\r\nChapters\r\n00:00 Introduction to BioTalk Unzipped at AAPS PharmSci 360\r\n03:45 Samaritan's Purse Charity and Community Impact\r\n05:16 Most impactful talk at AAPS?\r\n11:50 Comparative Analysis of FDA and EU Regulations\r\n17:37 The Drive Behind Bioanalytical Work\r\n22:24 NEW NEWS! - Innovations in RNA Editing and Bioanalysis\r\n\r\nTakeaways\r\n\u200bThe FDA's new rules on lab-developed tests could delay biomarker utilization in clinical trials.\r\n\u200bCommunity support through charities like Samaritan's Purse is crucial during crises.\r\n\u200bThe importance of collaboration in advancing drug development and bioanalytical methods.\r\n\u200bInnovations in RNA editing present new bioanalytical challenges.\r\n\u200bThe drive to help patients is a key motivator for professionals in the field.\r\n\u200b\r\nSound Bites\r\n\u200b\"I worked on that drug and there's a clear benefit.\"\r\n\u200b\"It's getting that new therapy to a patient.\"\r\n\u200b\"This is going to change and potentially delay biomarkers.\"\r\n\u200b\r\nNew News Story: \r\n\u200bWave sees RNA editing validation in early trial results\r\n\u25e6https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/ (https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/) \r\n\r\nHow to reach us:\r\nPlease donate to: Samaritan\u2019s Purse\r\nhttps://www.samaritanspurse.org/ (https://www.samaritanspurse.org/) \r\n\r\nMark Arnold\r\nhttps://www.linkedin.com/in/markearnoldphd/ (https://www.linkedin.com/in/markearnoldphd/) \r\nBlog - https://bioanalysisandbiomarkers.blogspot.com/ (https://bioanalysisandbiomarkers.blogspot.com/) \r\n \r\nDr. Chad Briscoe\r\nhttps://www.linkedin.com/in/chadbriscoe/ (https://www.linkedin.com/in/chadbriscoe/) \r\nCelerion - https://www.celerion.com/ (https://www.celerion.com/)  \r\n\r\nGregory Austin\r\nhttps://www.linkedin.com/in/gregoryaustin1/ (https://www.linkedin.com/in/gregoryaustin1/) \r\nECI - https://eci-rx.com/ (https://eci-rx.com) / \r\n\r\nImage Credits\r\n\u200bAAPS\r\n","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/768adeb5-0527-4dec-803d-997f1620c266/39803934-1701057614425-416945d0cee3.jpg"}